Tirzepatide reduces serum triglyceride irrespective of fibrate use in people with T2D at high CV risk (SURPASS-4)
DIABETES RESEARCH AND CLINICAL PRACTICE(2023)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
DIABETES RESEARCH AND CLINICAL PRACTICE(2023)